Poolbeg makes promising progress with RSV programme : vimars

Poolbeg Pharma revealed promising results from the lab-based analysis and prioritisation of respiratory syncytial virus (RSV) drug targets and treatments on Wednesday, driven by its artificial intelligence (AI) programme.

Related Keywords

Poolbeg Pharma , Jeremy Skillington , , Poolbeg , Makes , Promising , Progress , With , Programme , Category All , Category Market Report , Category Company News , Category News And Announcements , Category Small Caps News , Category Aim Bulletin , Category Tecnologia , Category Market Pulse , Mostread Small Caps ,